Showing results (371-380 of 483) with videos related to
Sort By:
Pageof 49
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 22, 2020
Alcohol-Mediated Renal Sympathetic Neurolysis for the Treatment of Hypertension: The Peregrine™ Infusion CatheterStefan Bertog, Alok Sharma, Felix Mahfoud, et al.Journal of the American College of Cardiology|June 30, 2022
Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of AgeMichael Böhm, Javed Butler, Gerasimos Filippatos, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 15, 2024
A novel, proof-of-concept radiofrequency renal denervation strategy to improve procedural efficiency: 12-month results from the SPYRAL DYSTAL pilot studyAndrew S P Sharp, David E Kandzari, Raymond R Townsend, et al.Revista Espanola De Cardiologia (English Ed.)|January 16, 2026
Evaluation of risk factor-weighted and coronary artery calcium score-weighted clinical likelihoods as gatekeepers before advance ischemia testingSimon M Frey, Igor G Schneider, Ann-Sophie Otto, et al.European Journal of Heart Failure|June 6, 2023
Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trialMichael Böhm, Javed Butler, Marcin Krawczyk, et al.Hypertension (Dallas, Tex. : 1979)|June 27, 2012
Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertensionFelix Mahfoud, Bodo Cremers, Julia Janker, et al.JACC. Clinical Electrophysiology|October 24, 2025
Risk Stratification in Left Bundle Branch Block After Transcatheter Aortic Valve Implantation: A Multicenter ECG Algorithm StudyPatrick Badertscher, Teodor Serban, Gregoire Massoullie, et al.Journal of the American College of Cardiology|September 24, 2021
Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood PressureMichael Böhm, Stefan D Anker, Javed Butler, et al.JACC. Cardiovascular Interventions|June 20, 2015
6-Month Outcomes in Patients With Implantable Cardioverter-Defibrillators Undergoing Renal Sympathetic Denervation for the Treatment of Refractory Ventricular ArrhythmiasLuciana V Armaganijan, Rodolfo Staico, Dalmo A R Moreira, et al.European Heart Journal|March 29, 2019
Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular riskMichael Böhm, Helmut Schumacher, Koon K Teo, et al.Pageof 49